Literature DB >> 10616212

Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection.

A Shrestha1, K Horino, H Nishiura, T Yamamoto.   

Abstract

A connection between the apoptotic cell clearance system and the acquired immune system was studied in vivo. When fluorescence-labeled apoptotic HL-60 cells were inoculated into footpads of guinea pigs and rabbits, monocyte/ macrophage infiltration rapidly occurred and subsequently the apoptotic cells as well as the macrophages disappeared from the lesion by 48 hours without any macroscopical signs of inflammation. Inversely, the fluorescent cell debris, which had been engulfed by the macrophages, appeared and chronologically increased in the draining lymphatics and the popliteal lymph nodes by 48 hours. Subsequently, proliferation of T and B lymphocytes in the popliteal lymph nodes was observed. Secondary inoculation of HL-60 cells in the flank skin of guinea pigs on day 3 after the initial inoculation induced an acute immunologic dermatitis with erythema, edema, vascular permeability enhancement, and polymorphonuclear leukocyte infiltration. In vitro characterizations demonstrated the presence of compliment dependent cytotoxic IgM antibody against HL-60 cells in their sera. The infiltration of monocytes/macrophages at the apoptotic cell injection site and the subsequent production of the anti-HL-60 cell IgM antibodies were significantly suppressed by in situ injections of anti-S19 ribosomal protein rabbit antibodies. These results indicated that the serial events with the rapid apoptotic cell clearance by macrophages, the macrophage migration to lymph nodes, and the antigen presentation to T lymphocytes by the macrophages acquire immunity against apoptotic cells. It was also indicated that the S19 ribosomal protein dimer was the major chemotactic factor in the initial monocyte/macrophage infiltration to apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10616212

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  5 in total

1.  Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion.

Authors:  Lei Shi; Shigeyuki Tsurusaki; Noriko Futa; Tamami Sakamoto; Tomoko Matsuda; Norikazu Nishino; Ryuji Kunitomo; Michio Kawasuji; Kazutaka Tokita; Tetsuro Yamamoto
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

2.  Distinct chemokine triggers and in vivo migratory paths of fluorescein dye-labeled T Lymphocytes in acutely simian immunodeficiency virus SIVmac251-infected and uninfected macaques.

Authors:  Candice C Clay; Denise S Rodrigues; Danielle J Harvey; Christian M Leutenegger; Ursula Esser
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  A plasma protein indistinguishable from ribosomal protein S19: conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation.

Authors:  Umeko Semba; Jun Chen; Yoshihiko Ota; Nan Jia; Hidetoshi Arima; Hiroshi Nishiura; Tetsuro Yamamoto
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

4.  Pro- and anti-apoptotic dual functions of the C5a receptor: involvement of regulator of G protein signaling 3 and extracellular signal-regulated kinase.

Authors:  Hiroshi Nishiura; Hideo Nonaka; Ivette S Revollo; Umeko Semba; Ying Li; Yoshihiko Ota; Atsushi Irie; Kumiko Harada; John H Kehrl; Tetsuro Yamamoto
Journal:  Lab Invest       Date:  2009-03-30       Impact factor: 5.662

5.  Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.

Authors:  Yan-Gao Man; Alexander Stojadinovic; Jeffrey Mason; Itzhak Avital; Anton Bilchik; Bjoern Bruecher; Mladjan Protic; Aviram Nissan; Mina Izadjoo; Xichen Zhang; Anahid Jewett
Journal:  J Cancer       Date:  2013-01-05       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.